Vaccines could offer hope - but who to vaccinate, and against what, has no clear answer yet. Read IMI Executive Director Dr Pierre Meulien’s perspective on what is needed to tackle antimicrobial resistance.
Vaccines are an effective public health measure, yet public distrust in immunisation is resulting in outbreaks of preventable diseases. IMI’s ADVANCE project worked to create an open system for monitoring vaccine coverage, benefits and risks in Europe.
Experts decry record-breaking scepticism towards vaccines across the EU and plead with member states to monitor attitudes and work to build public confidence
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.